PALM BEACH, Fla. – The first day of the National Association of Chain Drug Stores Annual Meeting got off to a fast start at a breakfast on GLP-1s sponsored by retailmediaIQ, publisher of Chain Drug Review and MMR. Building on a webinar devoted to the same topic earlier this year, the session addressed the latest developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors. Moderated by Parag Shah, co-founder, partner and chief growth officer at Think Blue, the panelists included Jim Kirby, chief commercial officer at Kroger Health, Betty Pio, a partner and strategic advisor to pharma and biotech at Kearney, and Sarah Squires, director of Retail Insights Drug Channel at NielsenIQ.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Latest
Seya Health launches Full Fiber
Austin-based women's health brand debuts at $24.99 on Seyahealth.com and Amazon, with female-focused creatine and hormone support formulas set for pipeline rollout.
Uqora report highlights hidden toll of UTIs on women’s health and daily lives
According to Uqora's UTI Impact Report, nearly half of women are willing to take a proactive approach to urinary health, signaling growing interest in prevention rather than treatment alone.
Meijer expands acceptance of evermore OTC spend cards for Medicare members
Midwest retailer adds another convenient payment option for eligible shoppers
CVS to pay $315 million to resolve DOJ opioid prescription allegations
The settlement resolves a lawsuit filed in 2024 alleging that CVS filled medically unnecessary prescriptions for opioids and other controlled substances, contributing to the nation's ongoing opioid crisis.